Troponin	O
I	O
inhibits	O
capillary	B-Cell
endothelial	I-Cell
cell	I-Cell
proliferation	O
by	O
interaction	O
with	O
the	O
cell	B-Cell
'	O
s	O
bFGF	O
receptor	O
.	O

Troponin	O
I	O
(	O
TnI	O
)	O
is	O
a	O
novel	O
cartilage	O
-	O
derived	O
angiogenesis	O
inhibitor	O
,	O
first	O
demonstrated	O
by	O
Moses	O
et	O
al	O
.	O

(	O
1999	O
,	O
Proc	O
.	O
Natl	O
.	O
Acad	O
.	O
Sci	O
.	O
USA	O
2645	O
-	O
2650	O
)	O
to	O
inhibit	O
endothelial	B-Cell
cell	I-Cell
proliferation	O
and	O
angiogenesis	O
,	O
both	O
in	O
vivo	O
and	O
in	O
vitro	O
,	O
and	O
to	O
inhibit	O
metastasis	O
of	O
a	O
wide	O
variety	O
of	O
tumors	B-Cancer
in	O
vivo	O
.	O

Despite	O
convincing	O
evidence	O
of	O
its	O
efficacy	O
,	O
little	O
is	O
known	O
about	O
the	O
mechanism	O
of	O
action	O
of	O
TnI	O
as	O
an	O
anti	O
-	O
proliferative	O
and	O
anti	O
-	O
angiogenic	O
agent	O
.	O

In	O
the	O
current	O
article	O
we	O
demonstrate	O
that	O
TnI	O
inhibits	O
both	O
bFGF	O
-	O
stimulated	O
and	O
basal	O
levels	O
of	O
endothelial	B-Cell
cell	I-Cell
proliferation	O
,	O
and	O
we	O
hypothesize	O
that	O
this	O
inhibition	O
is	O
occurring	O
,	O
at	O
least	O
in	O
part	O
,	O
via	O
an	O
interaction	O
of	O
TnI	O
with	O
the	O
cell	B-Cellular_component
-	I-Cellular_component
surface	I-Cellular_component
bFGF	O
receptor	O
on	O
capillary	B-Cell
endothelial	I-Cell
cells	I-Cell
.	O

We	O
further	O
support	O
this	O
hypothesis	O
by	O
providing	O
the	O
first	O
evidence	O
that	O
TnI	O
can	O
act	O
on	O
nonendothelial	B-Cell
as	O
well	O
as	O
endothelial	B-Cell
cells	I-Cell
and	O
by	O
demonstrating	O
that	O
this	O
inhibitory	O
action	O
is	O
specific	O
for	O
the	O
bFGF	O
receptor	O
on	O
the	O
target	O
cells	B-Cell
.	O

Preliminary	O
data	O
suggest	O
that	O
TnI	O
may	O
be	O
competing	O
with	O
bFGF	O
for	O
interaction	O
with	O
the	O
bFGF	O
receptor	O
on	O
responsive	O
cells	B-Cell
.	O

